Search Results - "Penn-Nicholson, Adam"

RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response.

Authors: Penn-Nicholson, Adam Mbandi, Stanley Kimbung Thompson, Ethan et al.

Source: Scientific Reports. 5/25/2020, Vol. 10 Issue 1, p1-21. 21p.

Oral Swab Testing With Xpert MTB/RIF Ultra for the Diagnosis of Tuberculosis in Children Aged <5 Years in Uganda: An Exploratory Interim Analysis of Diagnostic Accuracy in the NOD-pedFEND Cohort.

Authors: Khambati, Nisreen Moureen, Kanyange Angel Basile, Francesca Wanda et al.

Source: Open Forum Infectious Diseases. Apr2025, Vol. 12 Issue 4, p1-10. 10p.

In-home TB Testing Using GeneXpert Edge is Acceptable, Feasible, and Improves the Proportion of Symptomatic Household Contacts Tested for TB: A Proof-of-Concept Study.

Authors: Medina-Marino, Andrew Bezuidenhout, Dana Bezuidenhout, Charl et al.

Source: Open Forum Infectious Diseases. Jun2024, Vol. 11 Issue 6, p1-9. 9p.

Predicting tuberculosis risk - Authors' reply.

Authors: Zak, Daniel Scriba, Thomas J Hatherill, Mark et al.

Source: Lancet. 11/5/2016, Vol. 388 Issue 10057, p2233-2234. 2p.

Discovery and validation of a prognostic proteomic signature for tuberculosis progression: A prospective cohort study.

Authors: Penn-Nicholson, Adam Hraha, Thomas Thompson, Ethan G. et al.

Source: PLoS Medicine. 4/16/2019, Vol. 16 Issue 4, p1-21. 21p. 2 Charts, 5 Graphs.

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.

Authors: Scriba, Thomas J. Penn-Nicholson, Adam Shankar, Smitha et al.

Source: PLoS Pathogens. 11/16/2017, Vol. 13 Issue 11, p1-24. 24p.

Application of a whole blood mycobacterial growth inhibition assay to study immunity against Mycobacterium tuberculosis in a high tuberculosis burden population.

Authors: Baguma, Richard Penn-Nicholson, Adam Smit, Erica et al.

Source: PLoS ONE. 9/8/2017, Vol. 12 Issue 9, p1-19. 19p.

Performance of diagnostic and predictive host blood transcriptomic signatures for Tuberculosis disease: A systematic review and meta-analysis.

Authors: Mulenga, Humphrey Zauchenberger, Chambrez-Zita Bunyasi, Erick W. et al.

Source: PLoS ONE. 8/21/2020, Vol. 15 Issue 8, p1-17. 17p.

Predicting tuberculosis risk--reply.

Authors: Zak, Daniel Scriba, Thomas J. Hatherill, Mark et al.

Source: Lancet. 11/5/2016, Vol. 388 Issue 10057, p2233-2234. 2p.

Subjects: RNA, Tuberculosis risk factors, Cohort analysis

Potential population level impact on tuberculosis incidence of using an mRNA expression signature correlate-of-risk test to target tuberculosis preventive therapy.

Authors: Sumner, Tom Scriba, Thomas J. Penn-Nicholson, Adam et al.

Source: Scientific Reports. 7/31/2019, Vol. 9 Issue 1, pN.PAG-N.PAG. 1p.

Mixed Th1 and Th2 Mycobacterium tuberculosis-specific CD4 T cell responses in patients with active pulmonary tuberculosis from Tanzania.

Authors: Amelio, Patrizia Portevin, Damien Reither, Klaus et al.

Source: PLoS Neglected Tropical Diseases. 7/31/2017, Vol. 11 Issue 7, p1-26. 26p.

Co-regulation of innate and adaptive immune responses induced by ID93+GLA-SE vaccination in humans.

Authors: Fiore-Gartland, Andrew Srivastava, Himangi Seese, Aaron et al.

Source: Frontiers in immunology 2024.

Journal Info: Publisher: Frontiers Media S.A. ISSN: 1664-3224